{'52WeekChange': 0.74264014,
 'SandP52WeekChange': None,
 'address1': '12212 Technology Boulevard',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 35.4,
 'askSize': 900,
 'averageDailyVolume10Day': 997537,
 'averageVolume': 833896,
 'averageVolume10days': 997537,
 'beta': 0.67731,
 'beta3Year': None,
 'bid': 35.39,
 'bidSize': 800,
 'bookValue': 10.37,
 'category': None,
 'circulatingSupply': None,
 'city': 'Austin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 36.29,
 'dayLow': 35.11,
 'dividendRate': 0.36,
 'dividendYield': 0.0097,
 'earningsQuarterlyGrowth': -0.779,
 'enterpriseToEbitda': 71.168,
 'enterpriseToRevenue': 4.843,
 'enterpriseValue': 1659627136,
 'exDividendDate': 1592352000,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 32.099144,
 'fiftyTwoWeekHigh': 40.21,
 'fiftyTwoWeekLow': 17.35,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 36988140,
 'forwardEps': 0.32,
 'forwardPE': 110.56251,
 'fromCurrency': None,
 'fullTimeEmployees': 1257,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.05435,
 'heldPercentInstitutions': 0.8319,
 'industry': 'Medical Instruments & Supplies',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/luminexcorp.com',
 'longBusinessSummary': 'Luminex Corporation develops, manufactures, and sells '
                        'proprietary biological testing technologies and '
                        'products for the diagnostics, pharmaceutical, and '
                        'research industries worldwide. Its products include '
                        'Luminex 100/200 that integrates fluidics, optics, and '
                        'digital signal processing; FLEXMAP 3D system for use '
                        'as a general laboratory instrument; MAGPIX system, a '
                        'multiplexing analyzer for qualitative and '
                        'quantitative analysis of proteins and nucleic acids; '
                        'ARIES system, a sample to answer real-time PCR '
                        'platform; ARIES M1 system, a single-module version of '
                        'the ARIES System; and VERIGENE system, a '
                        'semi-automated, multiplex, molecular analysis system '
                        'for the clinical diagnostics market. The company also '
                        'provides MicroPlex, MagPlex, xTAG, SeroMAP, and '
                        'calibration and control microspheres; xPONENT, a '
                        'software suite to simplify laboratory workflow and '
                        'enhance productivity; SYNCT data management software '
                        'solutions; TDAS, an analysis program designed for '
                        'development and optimization of nucleic acid assays; '
                        'IDEAS, an image analysis software; and xTAG assays '
                        'and products to identify the causative agent for '
                        'respiratory and gastrointestinal infections, as well '
                        'as IVD kits for cystic fibrosis genotyping and '
                        'pharmacogenetic assays used to profile genetic '
                        'mutations related to drug metabolism. In addition, it '
                        'offers MultiCode assays and products comprising HSV '
                        '1&2 assays, and other products to detect infectious '
                        'agents in clinical samples; ARIES cassettes that are '
                        'self-contained assay consumables, such as ARIES HSV '
                        '1&2 assays, ARIES FLU A/B and RSV assays, ARIES group '
                        'A strep assays, ARIES bordetella assays, ARIES GBS '
                        'assay, and ARIES C. difficile assays; and VERIGENE '
                        'test cartridges, as well as operates as an original '
                        'equipment manufacturer of custom reagents and '
                        'instrumentation. The company serves pharmaceutical '
                        'companies, clinical laboratories, and research and '
                        'medical institutions. Luminex Corporation was founded '
                        'in 1995 and is based in Austin, Texas.',
 'longName': 'Luminex Corporation',
 'market': 'us_market',
 'marketCap': 1620046720,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_411496',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -6043000,
 'nextFiscalYearEnd': 1640908800,
 'open': 36.29,
 'openInterest': None,
 'payoutRatio': None,
 'pegRatio': 16.31,
 'phone': '512 219 8020',
 'previousClose': 36.7,
 'priceHint': 2,
 'priceToBook': 3.4117649,
 'priceToSalesTrailing12Months': 4.727937,
 'profitMargins': -0.01793,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 36.29,
 'regularMarketDayLow': 35.11,
 'regularMarketOpen': 36.29,
 'regularMarketPreviousClose': 36.7,
 'regularMarketPrice': 36.29,
 'regularMarketVolume': 396622,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 45789900,
 'sharesPercentSharesOut': 0.118599996,
 'sharesShort': 5430659,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 3997746,
 'shortName': 'Luminex Corporation',
 'shortPercentOfFloat': 0.1532,
 'shortRatio': 7.25,
 'startDate': None,
 'state': 'TX',
 'strikePrice': None,
 'symbol': 'LMNX',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': 0.33,
 'trailingAnnualDividendYield': 0.008991825,
 'trailingEps': -0.141,
 'twoHundredDayAverage': 29.00216,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'b117c7dd-1efa-323f-b52c-6aaee2beedfa',
 'volume': 396622,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.luminexcorp.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '78727'}